1 / 2

Sleep Apnea Devices Market

The report "Sleep Apnea Devices Market, By Diagnostic Devices (Polysomnography Devices, Pulse Oximeters, and Actigraphy Devices), By Therapeutic Devices (Positive Airway Pressure (PAP) Devices, (Continuous Positive Airway Pressure (CPAP) Devices, and Bi-Level Positive Airway Pressure (BiPAP) Devices), Oxygen Devices (Oxygen Concentrators, Portable Oxygen Concentrators, and Liquid Portable Oxygen), Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories), By End User (Sleep Laboratories and Hospitals, and Home Care Settings/Individuals).

User2019
Download Presentation

Sleep Apnea Devices Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sleep Apnea Devices Market worth US$ 5.9 Billion 2018 registering a significant CAGR of 7.80% over the forecast period Published Date: August 2020 The report "Sleep Apnea Devices Market, By Diagnostic Devices (Polysomnography Devices, Pulse Oximeters, and Actigraphy Devices), By Therapeutic Devices (Positive Airway Pressure (PAP) Devices, (Continuous Positive Airway Pressure (CPAP) Devices, and Bi-Level Positive Airway Pressure (BiPAP) Devices), Oxygen Devices (Oxygen Concentrators, Portable Oxygen Concentrators, and Liquid Portable Oxygen), Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories), By End User (Sleep Laboratories and Hospitals, and Home Care Settings/Individuals),and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Key Highlights: In September 2019, Philips unveils connected sleep apnea wearable NightBalance. In April 2017, In October 2017, Respicardia announced approval of Remed System from the U.S. FDA, for the treatment of moderate to severe central sleep apnea. The product approval in country significantly enhanced the company’s market presence in the U.S. and strengthen its revenue generation stream. In April 2017, Royal Philips announced the launch of Dream Series range, with an aim to improve sleep therapy experience for people with obstructive sleep apnea. The product launch enabled the company to strengthen its product portfolio and expand the customer base. Analyst View: Market Growth Drivers Increasing Incidences of Sleep Apnea Large pool of undiagnosed sleep apnea patients Rising Awareness and Technological advancement Rising demand for portable, efficient and superior sleep apnea devices Opportunities and Trends Increasing focus on telemedicine and mHealth (mobile health) Product innovation strategy adopted by key industry players Key Market Insights from the report: The market report has been segmented on the basis of diagnostic devices, therapeutic devices, end user, and region. By diagnostic devices, polysomnography devices led the market with 34.88% of revenue share in 2018 and is estimated to witness a CAGR of 7.05% over the forecast period. As there is no gold standard for diagnosis of OSA, polysomnography is one of the most preferred diagnostic tests for sleep apnea. By therapeutic devices, PAP Devices led the therapeutic segment due to higher product adoption and availability and comparative higher patient outcome. The segment is expected to witness a CAGR of 5.1% between 2019 and 2025. By end user, There is a growth in the number of sleep labs and sleep tests performed using a clinical polysomnography device globally, as these tests are being considered the standard diagnostic test for sleep apnea over a long period of time

  2. By regions, North America led the global market with a revenue share of 50.01% in 2018. Large patient pool and presence of established manufacturers are anticipated to further strengthen the regional market. Before purchasing this report, request a sample or make an inquiry by clicking the following link: https://www.prophecymarketinsights.com/market_insight/Insight/request- sample/4157 Competitive Landscape: The prominent player operating in the global sleep apnea devices market includes GE Healthcare, Fisher & Paykel Healthcare Limited, BMC Medical Co. Ltd, Cadwell Laboratories ResMed, Invacare Corporation, Braebon Medical Corporation, ImThera Medical Inc., Phillips Respironics, Curative Medical Inc., and Nihon Kohden The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report. Related Topics: https://www.prophecymarketinsights.com/market_insight/Global-Flat-Glass-Market-By-199 https://www.prophecymarketinsights.com/market_insight/Global-Inertial-Measurement-Unit- Market-3555 https://www.prophecymarketinsights.com/market_insight/global-spirometer-market-4526

More Related